Author Archives: admin
PRS PACE 2 Connell Manuscript FINAL VERSION ACCEPTED TO PRS
Patient-Activated Controlled Expansion (PACE) for Breast Reconstruction Utilizing Controlled Carbon Dioxide Inflation: Confirmation of aFeasibility Study Tony F. Connell, MBBS, BSc, FRACS Subiaco, Western Australia, Australia Interim results from the study described in this paper have been presented at the … Continue reading
ASPIRE FINAL DRAFT
Results from the ASPIRE Study for Breast Reconstruction Utilizing the AeroForm™ Controlled Carbon Dioxide-Inflated Tissue Expanders Tony F. Connell, MBBS, BSc, FRACS Subiaco, Western Australia, Australia CORRESPONDING AUTHOR CONTACT INFORMATION Tony F. Connell, MBBS, BSc, FRACS 3/200 Rokeby Road Subiaco … Continue reading
Updated Clinical Data from Numerous Studies of AirXpanders’ AeroForm™ Needle-Free, Patient-Controlled Tissue Expansion System to Be Presented at American Society of Plastic Surgeons (ASPS) Annual Meeting 2014
Presentations include the latest interim results from XPAND head-to-head pivotal study and data on whether AeroForm-implanted patients can undergo radiation therapy for residual breast cancer while completing the expansion process PALO ALTO, Calif., Oct. 6, 2014 /PRNewswire/ — The … Continue reading
New Published Study Shows That Radiation Can Be Delivered to Target Tissue Through the AeroForm™
New Published Study Shows That Radiation Can Be Delivered to Target Tissue Through the AeroForm™ Patient-Controlled Breast Tissue Expander Results indicate that breast cancer patients can receive adequate doses of radiation therapy while undergoing patient-controlled tissue expansion as part of … Continue reading
Interim Results of AirXpanders’ Multi-Centered Randomized Controlled Trial Demonstrate Faster, Needle-Free Alternative to Saline Tissue Expanders
Interim Results of AirXpanders’ Multi-Centered Randomized Controlled Trial Demonstrate Faster, Needle-Free Alternative to Saline Tissue Expanders Highly statistically significant improvement in expansion and total implant times compared to saline Interim results of the XPAND trial published in the April … Continue reading
AirXpanders Secures $7 million Senior Secured Credit Facility from GE Capital
AirXpanders Secures $7 million Senior Secured Credit Facility from GE Capital Credit facility to support completion of AeroForm™ U.S. pivotal trial and pre-commercialization activities BETHESDA, Md. and PALO ALTO, Calif. (April 2, 2014) – AirXpanders Inc., a company developing … Continue reading
AeroForm Approved in Australia
World’s First Needle-Free, Patient-Controlled Tissue Expansion Device for Women Undergoing Breast Reconstruction Following Mastectomy Approved in Australia Australia represents the first commercial market for AirXpanders’s AeroForm® Company to launch AeroForm to select plastic surgeons PALO ALTO, Calif. (November 4, 2013) … Continue reading
AirXpanders Data Shows Radiation Therapy After Mastectomy Does Not Affect Mechanism in AeroForm™ Expander
AirXpanders Data Shows Radiation Therapy After Mastectomy Does Not Affect Mechanism in AeroForm™ Expander PALO ALTO, Calif. (October 28, 2013) – AirXpanders Inc., a company developing novel technology for women who require tissue expansion for breast reconstruction following a mastectomy, … Continue reading
AirXpanders Announces European CE Mark Approval for AeroForm Patient
AirXpanders Announces European CE Mark Approval for AeroForm™ Patient-Controlled Tissue Expander for Patients Undergoing Breast Reconstruction PALO ALTO, Calif. (Oct 25, 2012) – AirXpanders Inc., a company developing novel technology for women who require tissue expansion for breast reconstruction following … Continue reading